Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ASTN2 antisense RNA 1 (ASTN2-AS1) is a long non-coding antisense RNA gene that is transcribed on the opposite strand of the protein-coding gene ASTN2. Its main postulated function is the regulation of the expression of ASTN2, likely through modulation of its mRNA stability, processing, or translation. Like other antisense RNAs, ASTN2-AS1 may play a role in fine-tuning gene expression but does not encode a protein or function as a classical drug target such as a receptor or enzyme. There is minimal direct experimental data characterizing its biological or disease impact as of now[3][6].
None established for drugs; possible gene regulation via antisense transcript effects
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ASTN2 antisense RNA 1 (ASTN2-AS1).